Short-acting somatostatin analogs can be used up to 24 hr before imaging with Ga 68 dotatate. Image patients with Ga 68 dotatate PET just prior to dosing with long-acting somatostatin analogs. Somatostatin analogs competitively bind to the same somatostatin receptors as Ga 68 dotatate and may affect imaging. Monitor Closely (1)pasireotide decreases effects of gallium Ga 68 dotatate by receptor binding competition. Monitor Closely (1)octreotide decreases effects of gallium Ga 68 dotatate by receptor binding competition. Monitor Closely (1)lanreotide decreases effects of gallium Ga 68 dotatate by receptor binding competition. Pasireotide decreases effects of gallium Ga 68 dotatate by receptor binding competition. Octreotide decreases effects of gallium Ga 68 dotatate by receptor binding competition. If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.Lanreotide decreases effects of gallium Ga 68 dotatate by receptor binding competition. The use of the eHealthMe site and its content is at your own risk.
Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. Different individuals may respond to medication in different ways. Our phase IV clinical studies alone cannot establish cause-effect relationship. WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.ĭISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider.
#NETSPOT KIT SOFTWARE#
Our analysis results are available to researchers, health care professionals, patients ( testimonials), and software developers ( open API).
Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. We study millions of patients and 5,000 more each day. With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials.
0 kommentar(er)
